Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term bi [Biosynthesis]. Found 10 abstracts

Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Research. 2005 May 15;65(10):4162-71.
Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 2005 Dec;65(4):331-40.
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
Gudima SO, Chang JH, Taylor JM. Features affecting the ability of hepatitis delta virus RNAs to initiate RNA-directed RNA synthesis. Journal of Virology. 2004 Jun;78(11):5737-44.
Isken O, Grassmann CW, Yu H, Behrens SE. Complex signals in the genomic 3' nontranslated region of bovine viral diarrhea virus coordinate translation and replication of the viral RNA. Rna-A Publication of the Rna Society. 2004 Oct;10(10):1637-52.
Jillella AP, Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?. Stem Cells & Development. 2004 Dec;13(6):598-606.
Subhi AL, Tang B, Balsara BR, Altomare DA, Testa JR, Cooper HS, Hoffman JP, Meropol NJ, Kruger WD. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clinical Cancer Research. 2004 Nov;10(21):7290-6.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term bi [Biosynthesis]

bi [Biosynthesis] me [Metabolism] Tumor Cell Line Non-US Gov't Research Support ge [Genetics] ph [Physiology] pa [Pathology] Female aa [Analogs & Derivatives] Apoptosis en [Enzymology] pd [Pharmacology] Transfection Proto-Oncogene Proteins c-bcl-2 rt [Radiotherapy] ad [Administration & Dosage] Viral RNA Breast Neoplasms de [Drug Effects] 0 (Proto-Oncogene Proteins c-bcl-2) Biological Models Cell Cycle Nucleic Acid Conformation Transcription Factors im [Immunology] Ovarian Neoplasms Non-US Gov't Support ch [Chemistry] ai [Antagonists & Inhibitors] 0 (Transcription Factors) Methylnitrosourea Blood Cell Count Loss of Heterozygosity Messenger RNA Viral) 0 (RNA 0 (Anticarcinogenic Agents) Base Sequence Guanine 0 (3' Untranslated Regions) N' -N-N'-N''-N''-pentaacetic acid) 9007-49-2 (dna) Single Nucleotide Polymorphism Purine-Nucleoside Phosphorylase 0 (Tumor Suppressor Protein p53) 363-24-6 (Dinoprostone) Gene Expression Combined Modality Therapy Tumor Suppressor Protein p53 Prostaglandin D2 Molecular Sequence Data Head and Neck Neoplasms Male 2-diamine (N-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1 ri [Radionuclide Imaging] 0 (Cell Cycle Proteins) Xenograft Model Antitumor Assays Genetic Translation 142434-84-2 Phenotype EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) 61-90-5 (Leucine) EC 3-4-21-75 (Furin) Phytogenic) 0 (Antineoplastic Agents Protein p16 Prostaglandin-Endoperoxide Synthase pc [Prevention & Control] mt [Methods] DNA Tumor Suppressor Genes Alleles SCID Mice CD34) 0 (Antigens EC 3-4-22 (Caspases) Furin 0 (Isothiocyanates) Alkylating Antineoplastic Agents 3' Untranslated Regions Antisense) 0 (DNA 0 (cyclin-dependent kinase Inhibitor p21) Fluorescence In Situ Hybridization Flow Cytometry CD34 Antigens human) EC 3-6-1 (PMS2 protein Human Chromosomes-Pair 9 EC 2-1-1-63 (O(6)-Methylguanine-DNA Methyltransferase) Neuroendocrine Tumors Anticarcinogenic Agents Cell Growth Processes 85622-93-1 (temozolomide) Glioma O(6)-Methylguanine-DNA Methyltransferase Protein Precursors pk [Pharmacokinetics] Alkylating) 0 (Antineoplastic Agents EC 3-4-22 (caspase 7) Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Cyclins) 67-43-6 (Pentetic Acid) ag [Agonists] Fluorenes Squamous Cell Carcinoma Multiple Drug Resistance th [Therapy] Immunotoxins Radioimmunotherapy Neoplasm Proteins 169590-42-5 (celecoxib) human) 0 (PLAGL1 protein Protein p53 Antisense DNA 0 (Cyclooxygenase Inhibitors) erbB-2) EC 2-7-1-112 (Receptor Western Blotting Pathologic Neovascularization Stem Cells bs [Blood Supply] 0 (Peptide Fragments) Drug Synergism 0 (Immunoglobulin Variable Region) Peptide Chain Termination Bone Marrow Cells 0 (Cyclin-Dependent Kinase Inhibitor p21) 684-93-5 (Methylnitrosourea) Rats Cattle 33069-62-4 (Paclitaxel) 23214-92-8 (Doxorubicin) mammalian) 0 (MLH1 protein 0 (Protein p16) 4342-03-4 (Dacarbazine) Isothiocyanates 0 (Yttrium Radioisotopes) ge [Genetics] Hepatitis Delta Virus Peptide Fragments Cell Line Pentetic Acid cy [Cytology] Cyclins 0 (Protein Precursors) EC 2-4-2-28 (5'-methylthioadenosine phosphorylase) Carcinogens 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Site-Directed Mutagenesis Ornithine Decarboxylase Experimental Mammary Neoplasms 0 (Fluorenes) Hematopoietic Stem Cell Transplantation Dacarbazine Pancreatic Neoplasms
Last updated on Thursday, April 02, 2020